Showing results (311-320 of 793) with videos related to
Sort By:
Pageof 80
Clinical Lymphoma, Myeloma & Leukemia|October 8, 2013
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphomaRajni Sinha, Pareen J Shenoy, Nassoma King, et al.British Journal of Haematology|April 25, 2007
Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myelomaPaul G Richardson, Pieter Sonneveld, Michael W Schuster, et al.The Lancet. Haematology|May 26, 2024
Pembrolizumab and low-dose, single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma: a prospective, single-centre, single-group, open-label, phase 2 pilot trial in the USAMohammad K Khan, Tahseen H Nasti, Joshua Y Qian, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working GroupAntonio Palumbo, Hervé Avet-Loiseau, Stefania Oliva, et al.Blood|June 13, 2014
Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patientsPaul G Richardson, Rachid Baz, Michael Wang, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantationAjay K Nooka, Heather R Johnson, Jonathan L Kaufman, et al.Nature Medicine|September 27, 2024
SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccinationDoan C Nguyen, Ian T Hentenaar, Andrea Morrison-Porter, et al.Blood|January 22, 2010
Stem cell transplantation in multiple myeloma: impact of response failure with thalidomide or lenalidomide inductionMorie A Gertz, Shaji Kumar, Martha Q Lacy, et al.Oncotarget|October 24, 2018
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myelomaUtkarsh Painuly, Vijay Ramakrishnan, Teresa Kimlinger, et al.Oncotarget|August 6, 2016
Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myelomaVijay Ramakrishnan, Marcus Gomez, Vivek Prasad, et al.Pageof 80